This project is part (Project 2) of the research consortium project """"""""Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamics."""""""" It will evaluate new gel and ring materials for delivery of microbicides to the vaginal lumen and epithelium. New in vitro and in vivo assays, and mathematical models, of gel distribution, drug delivery and HIV neutralization will be developed. Together with current techniques operational in our laboratory, this diversified set of performance analysis assays will provide feedback to Projects 1 and 3 of the research consortium. The in vitro assays and mathematical models will relate gel and ring properties and potency of active microbicidal ingredients to the extent that semen borne HIV is neutralized before it migrates into epithelium and initiates the transmission process. Current and new in vivo imaging techniques will map the coating of human vaginal epithelium by microbicide gels. This information will help enable Project 1 develop new gels and rings with properties optimized for good vaginal distribution and drug delivery. Interactions with Project 3 will link biophysical properties of the gels and rings to measures of their perception and acceptability by women. Together, Projects 1, 2 and 3 will create new microbicide gels and rings with properties co-optimized to provide good biological activity against HIV transmission and good behavioral acceptability by women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI077289-02
Application #
7910672
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
2
Fiscal Year
2009
Total Cost
$449,160
Indirect Cost
Name
Imquest Biosciences
Department
Type
DUNS #
146051664
City
Frederick
State
MD
Country
United States
Zip Code
21704
Gao, Yajing; Katz, David F (2017) Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema. PLoS One 12:e0167696
Funke, Claire; MacMillan, Kelsey; Ham, Anthony et al. (2016) Coupled gel spreading and diffusive transport models describing microbicidal drug delivery. Chem Eng Sci 152:12-20
Katz, David F; Yuan, Andrew; Gao, Yajing (2015) Vaginal drug distribution modeling. Adv Drug Deliv Rev 92:2-13
Morrow Guthrie, Kate; Vargas, Sara; Shaw, Julia G et al. (2015) The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. PLoS One 10:e0145642
Rosen, Rochelle K; van den Berg, Jacob J; Vargas, Sara E et al. (2015) Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings. Contraception 92:596-601
Ugaonkar, Shweta R; Clark, Justin T; English, Lexie B et al. (2015) An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission. J Pharm Sci 104:3426-39
Gao, Y; Yuan, A; Chuchuen, O et al. (2015) Vaginal deployment and tenofovir delivery by microbicide gels. Drug Deliv Transl Res 5:279-94
van den Berg, Jacob J; Rosen, Rochelle K; Bregman, Dana E et al. (2014) ""Set it and forget it"": women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav 18:862-70
Tolley, Elizabeth E; Morrow, Kathleen M; Owen, Derek H (2013) Designing a multipurpose technology for acceptability and adherence. Antiviral Res 100 Suppl:S54-9
Rastogi, Rachna; Teller, Ryan S; Mesquita, Pedro M M et al. (2013) Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa. Antiviral Res 100:255-8

Showing the most recent 10 out of 25 publications